Cabozantinib as a choice for platinum-refractory metastatic urothelial cancer

被引：1
|
作者：
Kikuchi, Eiji [1 ]
Hayakawa, Nozomi [1 ]
机构：
[1] St Marianna Univ, Dept Urol, Sch Med, Kawasaki, Kanagawa 2168511, Japan
来源：
LANCET ONCOLOGY | 2020年 / 21卷 / 08期
关键词：
D O I：
10.1016/S1470-2045(20)30236-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1006
页数：2
相关论文
共 50 条
  • [31] Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases
    Nishio, Kyosuke
    Higashio, Takuya
    Komura, Kazumasa
    Fukuokaya, Wataru
    Adachi, Takahiro
    Hirasawa, Yosuke
    Hashimoto, Takeshi
    Yoshizawa, Atsuhiko
    Tsuchida, Shuya
    Matsuda, Takuya
    Tsujino, Takuya
    Nishimura, Kazuki
    Tokushige, Satoshi
    Nakamori, Keita
    Uchimoto, Taizo
    Yamamoto, Shutaro
    Iwatani, Kosuke
    Urabe, Fumihiko
    Mori, Keiichiro
    Yanagisawa, Takafumi
    Tsuduki, Shunsuke
    Takahara, Kiyoshi
    Inamoto, Teruo
    Miki, Jun
    Kimura, Takahiro
    Ohno, Yoshio
    Shiroki, Ryoichi
    Azuma, Haruhito
    ONCOLOGY, 2024, 102 (06) : 457 - 464
  • [32] A phase II study of cabozantinib in patients (pts) with relapsed or refractory metastatic urothelial carcinoma (mUC)
    Apolo, Andrea B.
    Parnes, Howard L.
    Francis, Deneise C.
    Cordes, Lisa M.
    Berninger, Marilise
    Lamping, Elizabeth
    Costello, Rene
    Trepel, Jane B.
    Merino, Maria J.
    Folio, Les
    Lindenberg, Maria Liza
    Figg, William Douglas
    Steinberg, Seth M.
    Wright, John Joseph
    Madan, Ravi Amrit
    Ning, Yangmin M.
    Gulley, James L.
    Bottaro, Donald P.
    Dahut, William L.
    Agarwal, Piyush K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] A phase II study of cabozantinib in patients (pts) with relapsed or refractory metastatic urothelial carcinoma (mUC)
    Apolo, Andrea Borghese
    Parnes, Howard L.
    Madan, Ravi Amrit
    Gulley, James L.
    Wright, John Joseph
    Hoffman-Censits, Jean H.
    Dawson, Nancy Ann
    Trepel, Jane B.
    Khadar, Kattie
    Schlom, Jeffrey
    Merino, Maria
    Raffeld, Mark
    Steinberg, Seth M.
    Choyke, Peter L.
    Lindenberg, Maria Liza
    Folio, Les
    Agarwal, Piyush K.
    Figg, William Douglas
    Bottaro, Donald P.
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [34] Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
    Sridhar, Srikala S.
    Blais, Normand
    Ben Tran
    Reaume, M. Neil
    North, Scott A.
    Stockler, Martin R.
    Chi, Kim N.
    Fleshner, Neil E.
    Liu, Geoffrey
    Robinson, John W.
    Mukherjee, Som D.
    Rahim, Yasmin
    Winquist, Eric
    Booth, Christopher M.
    Nghia Trung Nguyen
    Beardsley, Emma K.
    Alimohamed, Nimira S.
    McDonald, Gail T.
    Ding, Keyue
    Parulekar, Wendy R.
    JAMA ONCOLOGY, 2020, 6 (11) : 1751 - 1758
  • [35] A phase II study of cabozantinib in patients (pts) with relapsed/refractory metastatic urothelial carcinoma (mUC)
    Nadal, R.
    Parnes, H. L.
    Francis, D. C.
    Cordes, L. M.
    Berninger, M.
    Costello, R.
    Folio, L.
    Linderberg, M.
    Machado, L.
    Steinberg, S. M.
    Wright, J. J.
    Ning, Y. M.
    Bottaro, D. P.
    Dahut, W. L.
    Apolo, A. B.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Salvage combination chemotherapy with irinotecan 5-fluorouracil and leucovorin for taxane- and platinum-refractory, metastatic gastric cancer
    Kim, Seung Tai
    Kang, Won Ki
    Song, Seo-Young
    Lee, Soon Il
    Nam, Eunmi
    Kim, Jung Han
    Park, Gun Woo
    Park, Joon Oh
    Park, Young Suk
    Park, Keunchil
    ANNALS OF ONCOLOGY, 2004, 15 : 234 - 235
  • [37] Recurrence within 6 months of platinum therapy: An adequate definition of "platinum-refractory" ovarian cancer?
    Markman, M
    GYNECOLOGIC ONCOLOGY, 1998, 69 (02) : 91 - 92
  • [38] Docetaxel for platinum-refractory advanced thymic carcinoma
    Watanabe, Naohiro
    Umemura, Shigeki
    Niho, Seiji
    Kirita, Keisuke
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Ohmatsu, Hironobu
    Goto, Koichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (07) : 665 - 669
  • [39] Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract
    Araki, Tomonori
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Kato, Ken
    Yamada, Yasuhide
    Hashimoto, Hironobu
    Taniguchi, Hirokazu
    Kushima, Ryoji
    Nakao, Kazuhiko
    Boku, Narikazu
    Shimada, Yasuhiro
    ANTI-CANCER DRUGS, 2016, 27 (08) : 794 - 799
  • [40] Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC)
    Sridhar, S. S.
    Canil, C. M.
    Mukherjee, S. D.
    Winquist, E.
    Elser, C.
    Eisen, A.
    Reaume, M. N.
    Zhang, L.
    Ko, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
12345